New Protein Aids in Cancer Cell Removal

A research group at kyoto University has engineered a novel ⁤protein, dubbed Crunch (connector for Removal of Unwanted Cell Habitat), designed to facilitate the removal of cancer cells from the body. The findings were published in Nature Biomedical Engineering on Wednesday, according to the university.

The ⁣Body’s Natural Cleanup Process

The research builds upon ‍the body’s natural cellular processes. More than 10⁤ billion cells die daily ⁢and are typically removed by ⁤immune cells called macrophages. Accumulation of these unnecessary cells, often due ‍to⁢ aging, can contribute to health problems like cancer and autoimmune diseases.

How Crunch Works

Crunch functions by binding to unwanted cells, essentially ⁤”marking” them for easier identification⁢ and removal by macrophages. Researchers note that the protein’s ⁤structure can be ‍modified to target different types of unwanted cells,⁤ offering potential versatility in treatment.

Promising Results ⁢in Animal Trials

In trials involving mice with skin ‍cancer or autoimmune diseases, injections of the Crunch protein ⁤demonstrated either suppressed cancer cell growth or a reduction in the number of harmful cells. These results suggest a potential therapeutic avenue for both cancer and autoimmune conditions.

Future Outlook and⁣ Clinical Trials

Kyoto University professor Jun ⁣Suzuki, a specialist in cell membrane biology, explained ⁣that current cancer treatments often focus on killing cancer cells before removal. He believes Crunch “will allow (cancer cells) to‍ be effectively removed while still alive, hopefully resulting in ⁣new forms of ⁣treatment.”

The research team anticipates initiating clinical trials on humans ‍within three years, with the aim of achieving practical application of the technology by the⁤ 2030s.